Post-transplantation lymphoproliferative disorders in Mexico: An aggressive clonal disease associated with epstein-barr virus type A

Modern Pathology

Volumn 11, Issue 2, 1998, Pages 200-208

  Lome Maldonado, Carmen ^a   Schwarzmann, Fritz ^c   Gredler, Evelyn ^b   Reyes, Edgardo ^a   Angeles Angeles, Arturo ^a   Fend, Falko ^b,d   Quintanilla Martínez, Leticia ^a,b,d  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Epstein Barr virus; Immunoglobulin gene rearrangement; LMP I deletion; Posttransplantation lymphoproliferative disorders

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; GANCICLOVIR; IMMUNOGLOBULIN LIGHT CHAIN; LATENT MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; OKT 3; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE SULFATE;

ADULT; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; GENE DELETION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TRANSPLANTATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MEXICO; PHENOTYPE; PRIORITY JOURNAL; VIRUS TYPING;

ADULT; ANTIGENS, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOPHENOTYPING; INTESTINAL NEOPLASMS; KIDNEY TRANSPLANTATION; LYMPHOMA, B-CELL; LYMPHOMA, LYMPHOBLASTIC; LYMPHOPROLIFERATIVE DISORDERS; MALE; MEXICO; MIDDLE AGED; ONCOGENE PROTEINS, VIRAL; POLYMERASE CHAIN REACTION; RNA, VIRAL; TUMOR VIRUS INFECTIONS; VIRAL MATRIX PROTEINS;

EID: 0345244855     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Swerdlow SH. Post-transplant lymphoproliferative disorders: a morphologic, phenotypic, and genotypic spectrum of disease. Histopathology 1992;20:373-85.
2. Frank D, Cesarman E, Liu Y, Michler R, Knowles D. Post-transplantation lymphoproliferative disorders frequently contain type A and not type B Epstein-Barr virus. Blood 1995;85:1396-403.
3. Borisch B, Finke J, Henning I, Delacretaz F, Schneider J, Heitz PU, et al. Distribution and localization of Epstein-Barr virus subtypes A and B in AIDS-related lymphomas and lymphatic tissue of HIV-positive patients. J Pathol 1992;168: 229-35.
4. Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, et al. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 1991;78:3004-10.
5. Hu L-F, Zabarovsky ER, Chen F, Cao S-L, Ernberg I, Klein G, et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP-1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991;72:2399-403.
6. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, et al. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992;7:2131-40.
7. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, et al. Deletions within the LMP-1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993;82:2937-42.
8. Sandvej K, Peh SC, Storstein Andreson B, Pallesen G. Identification of potential hotspots in the carboxyl-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated disease: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994;84:4053-60.
9. Smir BN, Hauke RJ, Bierman PJ, Gross TG, d'Amore F, Anderson JR, et al. Molecular epidemiology of deletions and mutations of the latent membrane protein-1 oncogene of the Epstein-Barr virus in posttransplant lymphoproliferative disorders. Lab Invest 1996;75:575-88.
10. Kingma DW, Shad A, Tsokos M, Fest T, Otsuki T, Frekko K, et al. Epstein-Barr virus (EBV)-associated smooth-muscle tumor arising in a post-transplant patient treated successfully for two PT-EBV-associated large-cell lymphomas. Am J Surg Pathol 1996;20:1511-9.
11. Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996;88:242-51.
12. Chen WG, Chen YY, Bacchi MM, Bacchi CE, Alvarenga M, Weiss LM. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue: type A with a high prevalence of deletions within the latent membrane-protein gene. Am J Pathol 1996;148:17-23.
13. Ambinder RF, Browning PJ, Lorenzana I, Leventhal BG, Cosenza H, Mann RB, et al. Epstein-Barr virus and childhood Hodgkin's disease in Honduras and the United States. Blood 1993;81:462-7.
14. Chang KL, Albujar PF, Chen Y-Y, Johnson RM, Weiss LM. High prevalence of Epstein-Barr virus in the Reed-Sternberg cells of Hodgkin's disease occurring in Peru. Blood 1993;81: 496-501.
15. Gulley ML, Eagan PA, Quintanilla-Martínez L, Picado AL, Smir BN, Childs C, et al. Epstein-Barr virus DNA is abundant and monoclonal in the Reed-Sternberg cells of Hodgkin's disease: association with mixed cellularity subtype and Hispanic-American ethnicity. Blood 1994;83:1595-601.
16. Quintanilla-Martínez L, Gamboa-Dominguez A, Gamez-Ledesma I, Angeles-Angeles A, Mohar A. Association of Epstein-Barr virus latent membrane protein and Hodgkin's disease in Mexico. Mod Pathol 1995;8:675-9.
17. Quintanilla-Martínez L, Lome-Maldonado C, Ott G, Gschwendtner A, Gredler E, Reyes E, et al. Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases. Blood 1997;89:644-51.
18. Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of post-transplantation lymphoproliferative disorders. Blood 1995; 85:552-65.
19. Frizzera G, Hanto DW, Gajl-Peczalska KJ, Rosai J, McKenna RW, Sibley RK, et al. Polymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res 1981;41:4262-71.
20. Frizzera G. Atypical lymphoproliferative disorders. In: Knowles D, editor. Neoplastic hematopathology. Baltimore: Williams & Wilkins; 1992. p. 459-96.
21. Rojas G, Alberœ J, Bordes-Aznar J, Quintanilla-Martínez L, Lome-Maldonado MC, Cesarman G, et al. Clinical and pathological characterization of post-transplantation lymphoproliferative disorders in kidney transplant recipients: single institution experience. Transplant Proc 1996;28:3317-20.
22. Fend F, Hittmair A, Rogatsch H, Gredler E, Obrist P, Mikuz G. Seminomas positive for Epstein-Barr virus by the polymerase chain reaction: viral RNA transcripts (EBERs) are present in intratumoral lymphocytes but absent from the neoplastic cells. Mod Pathol 1995;8:622-5.
23. Greer CE, Peterson SL, Kiviat NB, Manos MM. PCR amplification from paraffin-embedded tissues: effects of fixative and fixation time. Am J Clin Pathol 1991;95:117-24.
24. Herbst H, Niedobitek G, Kneba M, Hummel M, Finn T, Anagnostopoulos I, et al. High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am J Pathol 1990;137: 13-8.
25. Jilg W, Sieger E, Alliger P, Wolf H. Identification of type A and B isolates of Epstein-Barr virus by polymerase chain reaction. J Virol Meth 1990;30:319-22.
26. Fend F, Gschwendtner A, Gredler E, Thaler J, Dietze O. Detection of monoclonal B-cell populations in decalcified, plastic-embedded bone marrow biopsies with the polymerase chain reaction. Am J Clin Pathol 1994;102:850-5.
27. McCarthy MP, Sloane JP, Wiedemann LM. Rapid method for distinguishing clonal from polyclonal B-cell populations in surgical biopsy specimens. J Clin Pathol 1990;43:429-32.
28. Wan JH, Trainor KJ, Brisco MJ, Morley AA. Monoclonality in B-cell lymphoma detected in paraffin wax-embedded sections using the polymerase chain reaction. J Clin Pathol 1990;43:888-90.
29. Goldmann D, Merril CR. Silver staining of DNA in polyacrylamide gels: linearity and effect of fragment size. Electrophoresis 1982;3:24-6.
30. Cleary ML, Warnke R, Sklar J. Monoclonality of lymphoproliferative lesions in cardiac-transplant recipients: clonal analysis based on immunoglobulin-gene rearrangements. N Engl J Med 1984;135:477-82.
31. Cleary ML, Nalesnik MA, Shearer WT, Sklar J. Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood 1988;72:349-52.
32. Kaplan MA, Ferry JA, Harris NL, Jacobson JO. Clonal analysis of post-transplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers. Am J Clin Pathol 1994;101:590-6.
33. Locker J, Nalesnik M. Molecular genetic analysis of lymphoid tumors arising after organ transplantation. Am J Pathol 1989; 135:977-87.
34. Wu T-T, Swerdlow SH, Locker J, Bahler D, Randhawa P, Yunis EJ, et al. Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients. Hum Pathol 1996;27: 157-64.
35. Weiss LM, Wood GS, Trela M, Warnke RA, Sklar J. Clonal T-cell populations in lymphomatoid papulosis: evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med 1986;315:475-80.
36. Hanson CA, Frizzera G, Patton DF, Peterson BA, McClain KL, Gajl-Peczalska KJ, et al. Clonal rearrangement for immunoglobulin and T-cell receptor genes in systemic Castleman's disease: association with Epstein-Barr virus. Am J Pathol 1988;131:84-95.
37. Pelicci PG, Knowles DM, Wieczorek R, Wormser G, Arlin Z, Luciw P, et al. Multiple monoclonal B-cell expansions and c-myc gene rearrangement in AIDS-related lymphoproliferative disorders: implications for lymphomagenesis. J Exp Med 1986;164:2049-52.
38. Nalesnik MA, Jaffe R, Starzl TE, Demetris AJ, Porter K, Burnham J, et al. The pathology of post-transplant lymphoproliferative disorders (PTLDs) occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988;133:173-92.
39. Nalesnik MA. Involvement of the gastrointestinal tract by Epstein-Barr virus-associated post-transplant lymphoproliferative disorders. Am J Surg Pathol 1990;14(1 Suppl):92-100.
40. Penn I. Cancers following cyclosporine therapy. Transplantation 1987;43:32-5.
41. Penn I. Cancers complicating organ transplantation. N Engl J Med 1990;323:1767-9.
42. Guettier C, Hamilton-Dutoit S, Guillemain R, Farge D, Amrein C, Vulser C, et al. Primary gastrointestinal malignant lymphomas associated with Epstein-Barr virus after heart transplantation. Histopathology 1992;20:21-8.
43. Demetris AJ, Nalesnik MA, Kunz HW, Gill TJ III, Shinozuka H. Sequential analyses of the development of lymphoproliferative disorders in rats receiving cyclosporine. Transplantation 1984;38:239-46.
44. Osterhage DA, Steele PE, Witte D, Schroeder T, Yochman L, Swerdlow SH. T cells in post-transplant lymphoproliferative disorders (PTLD): an immunophenotypic and genotypic investigation [abstract]. Lab Invest 1992;66:85A.
45. Lynch EF, Jones PA, Swerdlow SH. CD43 and CD5 antibodies define four normal and neoplastic B-cell subsets: a three-color flow cytometric study. Cytometry 1995;22:223-31.
46. Moorthy R, Thorley-Lawson D. All three domains of Epstein-Barr virus-encoded latent membrane protein LMP-1 are required for transformation of rat-1 fibroblasts. J Virol 1993; 67:1638-46.
47. Santon A, Manzanal AI, Camlo E, Bellas C. Deletions in the Epstein-Barr virus latent membrane protein-1 oncogene in Hodgkin's disease. J Clin Pathol 1995;48:M184-M187.
48. Khanim F, Yao Q-Y, Niedobitek G, Sihota S, Rickinson AB, Young LS. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996; 88: 3491-501.
49. Smir B, Mowery R, Hinrichs S, Greiner M, Greiner T. Identification of LMP-1 gene deletion in reactive EBV-related disorders [abstract]. Mod Pathol 1996;9:123A.
50. Knecht H, Raphaël M, McQuain C, Rothenberger S, Pihan G, Camilleri-Brouet S, et al. Deletion variants within the NF-kB activation domain of the LMP-1 oncogene prevail in acquired immunodeficiency syndrome-related large cell lymphomas and human immunodeficiency virus-negative atypical lymphoproliferations. Blood 1996;87:876-81.
51. Scheinfeld AG, Nador RG, Chadburn A, Cesarman E, Knowles DM. Epstein-Barr virus latent membrane protein-1 oncogene deletion in post-transplantation lymphoproliferative disorders. Am J Pathol 1997;151:805-12.
52. Elenitoba-Johnson KSJ, Zarate-Osorno A, Meneses A, Krenacs L, Kingma DW, Raffeld M, et al. EBV strain type and LMP-1 oncogene deletions in nasal T/NK-cell lymphomas from Mexico [abstract]. Lab Invest 1997;76:124A.